Roche Diagnostics Head Schwan To Succeed Humer As CEO In 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
Appointment reflects increasing complexity of CEO, chairman roles, firm says. Humer will remain chairman of Roche.
You may also be interested in...
Genentech/Roche: The End Of An Era
Roche offers to buy out Genentech’s minority stakeholders for $89 per share, or $43.7 billion, to create the seventh largest U.S. pharma company.
Genentech/Roche: The End Of An Era
Roche offers to buy out Genentech’s minority stakeholders for $89 per share, or $43.7 billion, to create the seventh largest U.S. pharma company.
Roche Finally Gets A Nod With $3.4 Billion Bid For Ventana
After seven months and a half dozen attempts to acquire the diagnostics company, Roche wins over Ventana’s board with a sweetened bid .